Parkman Healthcare Partners’s IQVIA IQV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.8M Buy
86,702
+51,472
+146% +$10M 1.52% 21
2025
Q4
$7.94M Buy
35,230
+5,230
+17% +$1.14M 0.76% 45
2025
Q3
$5.7M Sell
30,000
-79,500
-73% -$14.5M 0.59% 60
2025
Q2
$17.3M Buy
+109,500
New +$16.5M 1.98% 17
2023
Q2
Sell
-45,643
Closed -$9.08M 99
2023
Q1
$9.08M Buy
45,643
+30,269
+197% +$6.47M 1.97% 19
2022
Q4
$3.15M Sell
15,374
-19,797
-56% -$4.02M 0.84% 45
2022
Q3
$6.37M Sell
35,171
-4,530
-11% -$992K 1.81% 19
2022
Q2
$8.62M Sell
39,701
-10,389
-21% -$2.26M 3.17% 7
2022
Q1
$11.6M Sell
50,090
-23,022
-31% -$5.45M 3.39% 7
2021
Q4
$20.6M Buy
73,112
+3,243
+5% +$842K 4.55% 1
2021
Q3
$16.7M Buy
69,869
+1,500
+2% +$379K 4.23% 5
2021
Q2
$16.6M Buy
68,369
+2,321
+4% +$536K 3.62% 6
2021
Q1
$12.8M Buy
66,048
+7,824
+13% +$1.47M 2.96% 9
2020
Q4
$10.4M Buy
58,224
+5,716
+11% +$963K 2.67% 8
2020
Q3
$8.28M Buy
52,508
+5,008
+11% +$785K 2.19% 13
2020
Q2
$6.74M Buy
47,500
+17,500
+58% +$2.37M 1.9% 21
2020
Q1
$3.24M Sell
30,000
-11,250
-27% -$1.61M 1.5% 25
2019
Q4
$6.37M Buy
+41,250
New +$6.02M 1.84% 23

Other funds holding IQV

Parkman Healthcare Partners's IQV Position: Q1 2026 in Review

Parkman Healthcare Partners increased its IQVIA (IQV) stake by 146% in Q1 2026, buying an estimated $10M and bringing the position to 86,702 shares worth $14.8M. The position accounts for 1.52% of the portfolio, ranked #21.

Parkman Healthcare Partners first reported a position in IQV in Q4 2019 and has held it in 18 quarters since. The position peaked at $20.6M in Q4 2021. 1,067 funds tracked by Wall St. Rank hold IQV as of Q1 2026.

  • Parkman Healthcare Partners held 86,702 shares of IQVIA worth $14.8M as of Q1 2026.
  • Parkman Healthcare Partners bought 51,472 IQVIA shares in Q1 2026, an estimated $10M.
  • IQVIA made up 1.52% of Parkman Healthcare Partners's portfolio in Q1 2026, its #21 holding.
  • Parkman Healthcare Partners first reported a position in IQVIA in Q4 2019 and has held it in 18 quarters since.
  • Parkman Healthcare Partners's IQVIA position peaked at $20.6M in Q4 2021.
  • 1,067 funds tracked by Wall St. Rank held IQVIA as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.